D ercole syndrome
D'Ercole Syndrome, also known as Fetal Growth Restriction (FGR) or Intrauterine Growth Restriction (IUGR), is a condition characterized by a fetus not reaching its genetically determined potential size. This medical condition can have significant implications for the health and development of the affected infant both before and after birth. Understanding D'Ercole Syndrome requires an exploration of its causes, diagnosis, treatment options, and potential outcomes for affected individuals.
Causes[edit | edit source]
The causes of D'Ercole Syndrome are multifactorial and can be broadly categorized into maternal, fetal, and placental factors. Maternal factors include conditions such as malnutrition, anemia, and pre-existing chronic diseases like diabetes and hypertension. Fetal factors might involve genetic abnormalities or infections. Placental factors refer to issues with the placenta itself, such as placental insufficiency, which leads to inadequate nutrient and oxygen delivery to the fetus.
Diagnosis[edit | edit source]
Diagnosis of D'Ercole Syndrome typically involves a combination of ultrasound measurements and maternal serum screening tests. Ultrasound can assess fetal size, amniotic fluid volume, and placental function, while maternal blood tests can help identify biomarkers indicative of placental insufficiency. In some cases, additional tests such as Doppler ultrasound may be used to evaluate blood flow in the umbilical artery, providing further insight into the health of the placenta and fetus.
Treatment[edit | edit source]
Treatment for D'Ercole Syndrome aims to improve fetal growth and prevent complications. Management strategies depend on the severity of the growth restriction and the gestational age of the fetus. In mild cases, increased maternal nutrition and monitoring may be sufficient. In more severe cases, hospitalization and closer monitoring of the fetus may be necessary. In critical situations, early delivery may be considered to prevent stillbirth or significant neonatal complications.
Outcomes[edit | edit source]
The outcomes for infants with D'Ercole Syndrome vary widely. Some infants may catch up in growth after birth, while others may experience long-term health and developmental issues. Complications can include neurological disorders, cardiovascular problems, and metabolic syndromes. Early intervention and supportive care can improve the prognosis for many affected infants.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD